June 11 (Reuters) - Novartis said on Thursday an experimental drug, which it acquired as part of its $12 billion takeover of ...

Novartis (NVS) says its RNA therapy braxlosiran (del-brax), added from its $12B acquisition of Avidity Biosciences in February, succeeded in a Phase 1/2 trial for facioscapulohumeral muscular ...

University of Maine researchers have published new findings about how muscles form, why certain muscle diseases develop and ...

University of Maine researchers have published new findings about how muscles form, why certain muscle diseases develop and ...

France-based pharma company Servier is acquiring the muscular dystrophy business of Edgewise Therapeutics as part of a ...

Peter Frampton, 76, discusses living with Inclusion Body Myositis, a rare, progressive muscle disease that is changing how he ...

Different types of liver disease are leading to distinct signatures of muscle loss, according to a new study that could help ...

Biomedical engineers have grown muscles in a lab to better understand and test treatments for a group of extremely rare muscle disorders called dysferlinopathy or limb girdle muscular dystrophies 2B ...

A new trial suggests apitegromab helps Mounjaro users preserve muscle while losing fat, potentially reducing unwanted muscle loss.

Musculoskeletal (MSK) disorders affect the muscles, bones, joints, and tissues. In children, they may be due to infection, cancer, inflammatory arthritis, or progressive muscle disorders. MSK ...